Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival.
Guilherme Freire Angotti CarraraAdriane Feijó EvangelistaCristovam Scapulatempo NetoLucas Faria Abrahao-MachadoMariana Andozia MoriniLigia Maria KerrMaria Aparecida Azevedo Koike FolgueiraRené Aloisio DA Costa VieiraPublished in: Breast cancer (Tokyo, Japan) (2020)
RPL37A is a potential biomarker for response to NCT and for prognosis. Additional studies evaluating HTRA1 and MTSS1 prognostic value are needed.